Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release

Biochemical Journal

Volumn 365, Issue 1, 2002, Pages 279-286

  Parthasarathy, Narayanan ^a   Torti, Suzy V ^a   Torti, Frank M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Ferritin binding protein; Inflammation; Protein interaction

Indexed keywords

BIOCHEMISTRY; MOLECULAR WEIGHT;

STERIC HINDERANCE;

PROTEINS;

BRADYKININ; FERRITIN; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; LIGAND;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; ENZYME ACTIVITY; ENZYME RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; STEREOSPECIFICITY;

BRADYKININ; FERRITINS; HUMANS; KALLIKREINS; KININOGEN, HIGH-MOLECULAR-WEIGHT; MODELS, BIOLOGICAL; PROTEIN BINDING;

EID: 0036646141     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20011637     Document Type: Article

References (57)

1. Ferritin: Structure, gene regulation, and cellular function in animals, plants, and microorganisms
2. Probing structure-function relationships in ferritin and bacterioferritin
3. The ferritins: Molecular properties, iron storage function and cellular regulation
4. Serum ferritin
5. A clinical evaluation of serum ferritin as an index of iron stores
6. The purification and properties of ferritin from human serum
7. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract
8. Interaction between rabbit erythroblast ferritin and normal plasma proteins
9. Interaction of ferritin with serum: Implications for ferritin turnover
10. Characteristics of a ferritin-binding protein present in human serum
11. Rabbit serum α-2-macroglobulin binds to liver ferritin: Association causes a heterogeneity of ferritin molecules
12. Characteristics and expression of binding sites specific for ferritin H-chain on human cell lines
13. Human placental ferritin receptor
14. Isolation of a human hepatic ferritin receptor
15. Pathways in the binding and uptake of ferritin by hepatocytes
16. Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells
17. Human H-kininogen is a ferritin-binding protein
18. The intrinsic coagulation/kinin-forming cascade: Assembly in plasma and cell surfaces in inflammation
19. Contact system: A vascular biology modulator with anticoagulant, profibronolytic, antiadhesive, and proinflammatory attributes
20. Human high molecular weight kininogen
21. Completion of the primary structure of human high-molecular-mass kininogen
22. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma
23. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI
24. Studies on human kininogens
25. Bioregulation of kinins kallikreins, kininogens, and kininases
26. The binding of high molecular weight kininogen to cultured human endothelial cells
27. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage
28. Assembly of contact-phase factors on the surface of the human neutrophil membrane
29. Characterization of the H-kininogen binding site on factor XI
30. High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5)
31. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: Identity with the receptor that binds to the globular "heads" of C1q (gC1q-R)
32. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor
33. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells
34. Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254
35. Platelet glycoprotein Ib: A zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen
36. The plasma kallikrein-kinin system in sepsis, inflammatory arthritis, and enterocolitis
37. The kinin system in rhinitis and asthma
38. Iron and ferritin in inflammation and cancer
39. Potent, long-acting bradykinin antagonists for a wide range of applications
40. Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1
41. Serum ferritin
42. Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein
43. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein-like activity in human plasma
44. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
45. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma
46. Limited proteolysis of human low-molecular-mass kininogen by tissue kallikrein
47. The shape of high molecular weight kininogen
48. The characteristics of ferritin from human tissues, serum and blood cells
49. Platelet high-molecular-weight kininogen
50. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis
51. Human serum ferritin G-peptide is recognized by anti-L ferritin subunit antibodies and concanavalin-A
52. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation
53. Role of the light chain of high molecular weight kininogen in adhesion, cell-associated proteolysis and angiogenesis
54. Plasma bradykinin in angio-oedema
55. Increase in blood bradykinin concentration after eccentric weight-training exercise in men
56. Removal of low-density lipoprotein from plasma by adsorption increases bradykinin and plasma nitric oxide levels in patients with peripheral atherosclerosis
57. Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans